To establish the toxicological profile of new compounds or to extend the known profiles of existing one (new indications, new formulations, new routes of administration…), ERBC offers a full range of services covering from exploratory programs to fully GLP-compliant toxicology studies. The latter range from acute to chronic toxicity, with different species and multiple routes of administration, to specialty toxicology. These data support human clinical trials and marketing authorization approval around the world.
Today, the company is a leading innovator in the discipline. ERBC scientists develop advanced tools, assays and models that contribute to reduce the use of animals and improve data predictivity and participate in interdisciplinary working groups that shape the future of toxicology.